Vasculopathy Related to Manic/Hypomanic Symptom Burden and First-Generation Antipsychotics in a Sub-Sample from the Collaborative Depression Study
Psychotherapy and Psychosomatics, Exclusive Author Commentary  Clinical Article

Fiedorowicz JG et al. – The results provide evidence that chronicity of mood symptoms contribute to vasculopathy in a dose–dependent fashion. Patients with more manic/hypomanic symptoms had poorer endothelial function. First–generation antipsychotic exposure was associated with arterial stiffness, evidenced by higher augmentation pressure, perhaps secondary to elevated blood pressure. Vascular phenotyping methods may provide a promising means of elucidating the mechanisms linking mood disorders to vascular disease.

Methods
  • Participants with mood disorders were recruited for the National Institute of Mental Health Collaborative Depression Study (CDS) and followed prospectively.
  • A cross-sectional metabolic and vascular function evaluation was performed on a sub-sample near completion after a mean follow-up of 27 years.

Results
  • A total of 35 participants from the University of Iowa (33) and Washington University (2) sites of the CDS consented to a metabolic and vascular function assessment at the Iowa site.
  • In multivariate linear regression, controlling for age, gender, and smoking, manic/hypomanic, but not depressive, symptom burden was associated with lower flow-mediated dilation.
  • Cumulative exposure to antipsychotics and mood stabilizers was associated with elevated augmentation pressure and mean aortic systolic blood pressure.
  • This appeared specifically related to first-generation antipsychotic exposure and mediated by increases in brachial systolic pressure.
  • Although second-generation antipsychotics were associated with dyslipidemia and insulin resistance, they were not associated with vasculopathy.

In a prior analysis of 435 individuals with bipolar disorder from the Collaborative Depression Study (CDS), we found manic/hypomanic symptom burden (chronicity of clinically significant manic/hypomanic symptomatology) was significantly associated with cardiovascular mortality (Fiedorowicz et al. Psychosom Med 2009). This appeared to account for the greater risk of cardiovascular mortality in bipolar I, relative to bipolar II disorder as observed in the CDS sample and the only prior study to assess mortality differences by bipolar subtype (Angst F et al. J Affect Disord 1994). We were interested in replicating and extending the prior finding. To do so, we recruited a small subset of participants from the CDS, whose course of illness had been prospectively assessed for over a quarter century through participation, for a quantitative metabolic and vascular phenotyping assessment. We analogously found a dose-response relationship between manic/hypomanic symptom burden and endothelial dysfunction, based on a relationship with poorer flow-mediated but not nitroglycerin-mediated vasodilation. While difficult to study as reliable data is seldom available, the assessment of a dose-response between the long-term chronicity of illness and vascular outcomes circumvents some of the issues related to selection bias in case control studies (e.g. inpatient registry compared to national data) and provides additional evidence for a causal relationship between bipolar disorder and vascular disease. Such methods may assist in the identification of the most relevant mechanisms mediating the well-established relationship between bipolar disorder and vascular mortality (reviewed by Murray et al. Curr Psychiatry Rep 2009; Weiner M et al. Ann Clin Psychiatry 2011). References: Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 2002;68:167-81. Fiedorowicz JG, Coryell WH, Rice JP, Warren LL, Haynes WG. Vasculopathy Related to Manic/Hypomanic Symptom Burden and First-Generation Antipsychotics in a Sub-Sample from the Collaborative Depression Study. Psychotherapy and Psychosomatics 2012;81:235-43. Fiedorowicz JG, Solomon DA, Endicott J, Leon AC, Li C, Rice JP, et al. Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder. Psychosom Med 2009;71:598-606. Murray DP, Weiner M, Prabhakar M, Fiedorowicz JG. Mania and mortality: why the excess cardiovascular risk in bipolar disorder? Curr Psychiatry Rep 2009;11:475-80. Weiner M, Warren L, Fiedorowicz JG. Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry 2011;23:40-7.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Psychiatry

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Psychiatry Articles

1 Zolpidem and the risk of Parkinson's disease: A nationwide population-based study Journal of Psychiatric Research, August 1, 2014    Clinical Article

2 Vascular Endothelial Growth Factor: A potential diagnostic biomarker for major depression Journal of Psychiatric Research, September 19, 2014    Clinical Article

3 Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: A systematic review and meta-analysis of randomized clinical trials JAMA Psychiatry, October 22, 2014    Evidence Based Medicine    Clinical Article

4 Comparative efficacy and acceptability of drug treatments for bipolar depression: A multiple-treatments meta-analysis Acta Psychiatrica Scandinavica, October 10, 2014    Evidence Based Medicine    Clinical Article

5 Antidepressants and the risk of hyponatraemia: A class-by-class review of the literature Psychosomatics, September 15, 2014    Review Article

6 Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis Schizophrenia Research, September 24, 2014    Clinical Article

7 Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls Bipolar Disorders, October 3, 2014    Clinical Article

8 Diffusion tensor imaging predictors of treatment outcomes in major depressive disorder The British Journal of Psychiatry, October 8, 2014    Clinical Article

9 A comparison between phone-based psychotherapy with and without text messaging support in between sessions for crisis patients Full Text Journal of Medical Internet Research, October 13, 2014    Free full text    Clinical Article

10 Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression International Journal of Neuropsychopharmacology, October 2, 2014    Clinical Article

11 Association of ARRB1 polymorphisms with the risk of major depressive disorder and with treatment response to mirtazapine Journal of Psychopharmacology, October 16, 2014    Clinical Article

12 Cognitive improvement of attention and inhibition in the late afternoon in children with attention-deficit hyperactivity disorder (ADHD) treated with osmotic-release oral system methylphenidate Journal of Child Neurology, October 15, 2014    Clinical Article

13 Prazosin in the treatment of PTSD Journal of Psychiatric Practice, July 25, 2014    Review Article

14 Guanfacine for attention deficit and hyperactivity disorder in pediatrics: a systematic review and meta-analysis European Neuropsychopharmacology, September 2, 2014    Evidence Based Medicine    Review Article

15 Attention-deficit/hyperactivity disorder and adverse health outcomes in adults The Journal of Nervous and Mental Disease, October 29, 2014    Clinical Article

16 Therapist-assisted Internet–delivered Cognitive Behavior Therapy for depression and anxiety: Translating evidence into clinical practice Journal of Anxiety Disorders, October 17, 2014    Clinical Article

17 Effects of post-session administration of methylene blue on fear extinction and contextual memory in adults with claustrophobia American Journal of Psychiatry, October 6, 2014    Evidence Based Medicine    Clinical Article

18 Internet-delivered exposure-based cognitive-behavioural therapy and behavioural stress management for severe health anxiety: Randomised controlled trial The British Journal of Psychiatry, October 14, 2014    Clinical Article

19 Psychiatric correlates of alcohol and tobacco use disorders in U.S. adults aged 65 years and older: Results from the 2001-2002 National Epidemiologic Survey of Alcohol and Related Conditions The American Journal of Geriatric Psychiatry, October 9, 2014    Clinical Article

20 Cigarette smoking and the onset and persistence of depression among adults in the United States: 1994-2005 Comprehensive Psychiatry, October 28, 2014    Clinical Article

Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addictionmore